search
Back to results

Prediction of Adverse Outcome Using Fetal MRI in Pregnancies at Risk of Preterm Birth

Primary Purpose

Preterm Birth Complication

Status
Recruiting
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
MRI scan
Sponsored by
King's College London
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Preterm Birth Complication

Eligibility Criteria

16 Years - undefined (Child, Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • pregnant women with uncomplicated pregnancies 16-42 weeks pregnant OR
  • pregnant women at high risk of preterm birth before 32 weeks gestation

Exclusion Criteria:

  • inability to give informed consent
  • multiple pregnancy
  • gestational diabetes
  • pre-eclampsia
  • fetuses known to have chromosomal or fetal abnormalities
  • a recently sited maternal metallic implant, claustrophobia.

Sites / Locations

  • St Thomas' Hospital, King's College LondonRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

High risk of preterm birth

Women with low risk pregnancies

Arm Description

Women at high risk of preterm birth

Women with uncomplicated pregnancies anticipated to deliver at term

Outcomes

Primary Outcome Measures

Number of participants with chorioamnionitis
Chorioamnionitis will be diagnosed on placental histology
Neonatal morbidity
A composite neonatal adverse outcome will be created

Secondary Outcome Measures

Individual adverse neonatal outcomes
Specific neurological, respiratory, GI and individual systems adverse outcomes for the neonate

Full Information

First Posted
November 15, 2021
Last Updated
March 29, 2022
Sponsor
King's College London
Collaborators
National Institute for Health Research, United Kingdom, Guy's and St Thomas' NHS Foundation Trust, Massachusetts Institute of Technology, Boston Children's Hospital, Phoenix Children's Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05164432
Brief Title
Prediction of Adverse Outcome Using Fetal MRI in Pregnancies at Risk of Preterm Birth
Official Title
Individualised Risk Prediction of Adverse Neonatal Outcome in Pregnancies That Deliver Preterm Using Advanced MRI Techniques and Machine Learning
Study Type
Interventional

2. Study Status

Record Verification Date
November 2021
Overall Recruitment Status
Recruiting
Study Start Date
December 1, 2021 (Actual)
Primary Completion Date
November 1, 2025 (Anticipated)
Study Completion Date
November 1, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
King's College London
Collaborators
National Institute for Health Research, United Kingdom, Guy's and St Thomas' NHS Foundation Trust, Massachusetts Institute of Technology, Boston Children's Hospital, Phoenix Children's Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
1.4% of babies have a very premature birth (PTB) (less than 32 weeks of pregnancy). This can result in severe life-long complications including cerebral palsy, learning and behavioural difficulties and breathing problems. This has significant cost implications for the NHS, education services and immeasurable human costs for the child and their family. Early delivery may result from maternal infection or poor attachment of the placenta to the womb, which may also cause abnormal brain and lung development. Even where obvious signs of infection are not present in the mother, subtle infection is often present in the baby. Currently there is no test routinely used to see if there is an infection of the baby inside the womb, and it is unknown how the placenta develops in babies that subsequently deliver preterm. Using MRI, the investigators will assess the baby's thymus and placenta for signs of infection and assess how the lungs and brain are developing whilst still in the womb. Machine learning techniques, where computers analyze all the results together, will then be used to see if these scans can identify babies that do poorly after birth. 137 pregnant women at high risk of PTB (between 16-32 weeks of pregnancy) and 183 women with uncomplicated pregnancies will be invited to participate. Women will have an MRI scan of the fetus assessing the lung, brain, thymus and placenta. Where high risk women do not deliver, repeat imaging will be offered every two weeks (maximum 3). After birth the investigators will see if infection was present by analysing the placenta under a microscope, and see how the baby does. All the information from scans and after birth will be put into a computer, to predict which babies do poorly after birth. Health records of the child will be accessed up to two years of age.
Detailed Description
1.4% of babies have a very premature birth (PTB) (less than 32 weeks of pregnancy). This can result in severe life-long complications including cerebral palsy, learning and behavioural difficulties and breathing problems. Besides immeasurable human costs for the baby and family this also has significant cost implications for the NHS. Infection may cause both early delivery and subsequent abnormal brain and lung development. Where obvious signs of infection are not present in the mother, subtle infection is often present in the unborn baby. Currently there is no test routinely used to see if there is an infection of the baby in the womb. Fetal Magnetic Resonance Imaging (MRI), already used in clinical practice, can produce very clear images of the baby's brain and lungs. It can also assess blood flow and structure in detail, as well as overall size. The investigators already have data, which shows areas of the brain and lungs are smaller in babies that subsequently deliver very preterm, indicating factors that drive preterm birth may already be affecting how the baby develops in the womb. MRI can also give information regarding infection in the fetus by measuring an organ in the neck (the thymus) vital to the baby's immune system and by scanning the placenta. The investigators have new data that suggests that these methods could help pick up infection. Women who have previously undergone preterm birth have helped shape this study. Aims The investigators want to ascertain if it is possible to predict which babies are likely to develop serious complications after preterm birth. Using MRI, the thymus and placenta will be assessed for signs of infection and how the lungs and brain are developing whilst still in the womb will be monitored. The investigators will evaluate if these scans accurately identify the babies that do poorly after birth. Study Design 75 pregnant women at high risk of PTB (between 16- 32 weeks of pregnancy) and 100 women with uncomplicated pregnancies will be invited to participate. Women will be identified as high-risk if: they have no symptoms but are, attending the Preterm Surveillance Clinic at St Thomas's Hospital, with risk factors for PTB (a previous premature delivery or surgery to the neck of the womb (cervix)) and are likely to deliver early, which we can pick up by seeing if the cervix has already shortened, and by doing a vaginal swab test. they have lost the fluid (waters) around the baby the cervix has opened before 24 weeks These women will have an MRI scan of the fetal lung, brain, thymus and placenta. Repeat imaging will be offered every two weeks (maximum of three scans). After birth the investigators will see if infection is present by analysing the umbilical cord blood and looking at the placenta under a microscope. Information about complications the babies have until they leave hospital will be collected. All of this information, as well as from scans from healthy pregnant women involved in other research studies both in this country and from abroad, will be combined in a new test, using 'machine learning', which involves computers analysing the data to see if babies most likely to have problems after birth can be identified. Results will be presented in scientific papers, at conferences and through social media. If the test works, the next step would be to find out when the best time is to deliver the baby; this may be sooner if the fetus is known to have an infection. The appropriate timing of existing treatments to prevent brain and lung injury may also be facilitated with more studies in the future.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Preterm Birth Complication

7. Study Design

Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Two groups of women will be recruited those at high risk of preterm birth and those who have uncomplicated pregnancies
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
175 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
High risk of preterm birth
Arm Type
Experimental
Arm Description
Women at high risk of preterm birth
Arm Title
Women with low risk pregnancies
Arm Type
Active Comparator
Arm Description
Women with uncomplicated pregnancies anticipated to deliver at term
Intervention Type
Diagnostic Test
Intervention Name(s)
MRI scan
Intervention Description
Women will have an MRI scan during pregnancy to evaluate the fetus and placenta
Primary Outcome Measure Information:
Title
Number of participants with chorioamnionitis
Description
Chorioamnionitis will be diagnosed on placental histology
Time Frame
After delivery (within approximately three months of recruitment depending on the gestation at delivery)
Title
Neonatal morbidity
Description
A composite neonatal adverse outcome will be created
Time Frame
Neonatal period post delivery (up to approximately seven months after recruitment depending on the gestation at delivery)
Secondary Outcome Measure Information:
Title
Individual adverse neonatal outcomes
Description
Specific neurological, respiratory, GI and individual systems adverse outcomes for the neonate
Time Frame
Neonatal period post delivery (up to approximately seven months after recruitment depending on the gestation at delivery)

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
Pregnant women will be recruited
Minimum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: pregnant women with uncomplicated pregnancies 16-42 weeks pregnant OR pregnant women at high risk of preterm birth before 32 weeks gestation Exclusion Criteria: inability to give informed consent multiple pregnancy gestational diabetes pre-eclampsia fetuses known to have chromosomal or fetal abnormalities a recently sited maternal metallic implant, claustrophobia.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lisa Story, MD PhD
Phone
020 7188 7083
Email
lisa.story@kcl.ac.uk
First Name & Middle Initial & Last Name or Official Title & Degree
Reza Razavi, MD PhD
Phone
02078483224
Email
reza.razavi@kcl.ac.uk
Facility Information:
Facility Name
St Thomas' Hospital, King's College London
City
London
State/Province
Greater London
ZIP/Postal Code
SE1 7EH
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lisa Story, MD PhD
Phone
020 7188 7083
Email
lisa.story@kcl.ac.uk
First Name & Middle Initial & Last Name & Degree
Jana Hutter, PhD
Phone
020 7188 7083
Email
jana.hutter@kcl.ac.uk
First Name & Middle Initial & Last Name & Degree
Lisa Story, MD PhD

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Anonymised data will be shared with other researchers
IPD Sharing Time Frame
Data is suitable for sharing in anonymised form. It is intended that the data will be made available on completion of data collection and publication of findings.
IPD Sharing Access Criteria
Data can be used for academic purposes. Users are bound by a data sharing agreement which does not allow the commercial use of the data and sets out their responsibilities to acknowledge publications and funding associated with the data, not attempting to de-anonymise and identify any subjects as well as their duty to inform the research team of any relevant observations and results.

Learn more about this trial

Prediction of Adverse Outcome Using Fetal MRI in Pregnancies at Risk of Preterm Birth

We'll reach out to this number within 24 hrs